Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenaya Therapeutics Inc

0.4550
+0.01503.41%
Pre-market: 0.48000.0250+5.49%09:24 EST
Volume:11.77M
Turnover:5.76M
Market Cap:36.05M
PE:-0.32
High:0.5200
Open:0.5155
Low:0.4510
Close:0.4400
Loading ...

Optimistic Outlook for Tenaya Therapeutics Amid Positive Trial Developments for TN-201

TIPRANKS
·
22 Oct 2024

TD Cowen Sticks to Their Buy Rating for Tenaya Therapeutics (TNYA)

TIPRANKS
·
21 Oct 2024

Promising Developments and DSMB Approval Drive Buy Rating for Tenaya Therapeutics

TIPRANKS
·
18 Oct 2024

Analysts Are Bullish on Top Healthcare Stocks: Tenaya Therapeutics (TNYA), Elevance Health (ELV)

TIPRANKS
·
18 Oct 2024

Tenaya Therapeutics (TNYA) Receives a Buy from Piper Sandler

TIPRANKS
·
18 Oct 2024

Positive Buy Rating for Tenaya Therapeutics Amid Progress in TN-201 Gene Therapy and Clinical Trial Advancements

TIPRANKS
·
18 Oct 2024

Tenaya Therapeutics provides updates on MyPEAK-1 clinical trial of TN-201

TIPRANKS
·
18 Oct 2024

BRIEF-Tenaya Therapeutics Announces Updates On TN-201 Gene Therapy Program For MYBPC3-Associated HCM

Reuters
·
18 Oct 2024

Tenaya Therapeutics Announces Updates on Tn-201 Gene Therapy Program for Mybpc3-Associated HCM

THOMSON REUTERS
·
18 Oct 2024

Tenaya Therapeutics Inc - Initial Data From Cohort 1 to Be Reported in December 2024

THOMSON REUTERS
·
18 Oct 2024

Tenaya Therapeutics : Independent Data Safety & Monitoring Board Endorsed Dose Escalation & Broadening of Eligibility Criteria; Cohort 2 NOW Enrolling

THOMSON REUTERS
·
18 Oct 2024

Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM

GlobeNewswire
·
18 Oct 2024

Buy Rating Justified by Tenaya Therapeutics’ Promising Gene Therapy Advancements

TIPRANKS
·
11 Oct 2024

Buy Rating Reiterated on Tenaya Therapeutics Amid Promising Gene Therapy Prospects for HCM

TIPRANKS
·
24 Sep 2024

Owning 43% shares,institutional owners seem interested in Tenaya Therapeutics, Inc. (NASDAQ:TNYA),

Simply Wall St.
·
21 Sep 2024

Tenaya Therapeutics Announces Board Restructuring and New Equity Plan

TIPRANKS
·
17 Sep 2024